Controlled Release of TGF-β3 for Effective Local Endogenous Repair in IDD Using Rat Model.

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Nanotechnology

Background:

• Intervertebral disc degeneration (IDD) is a prevalent musculoskeletal disease with limited treatment options.
• The acidic and oxidative microenvironment of degenerative discs hinders current regenerative strategies.
• Developing advanced biomaterials is crucial for effective IDD therapy.

Purpose of the Study:

• To engineer an intelligent, biodegradable nanoplatform using hollow manganese dioxide (H-MnO2) for IDD treatment.
• To investigate the capacity of the nanoplatform to modulate the degenerative microenvironment.
• To evaluate the therapeutic potential of releasing transforming growth factor beta-3 (TGF-β3) for IDD.

Main Methods:

• Characterization of H-MnO2 nanoparticles (NPs) using electron microscopy and spectroscopy.
• Assessment of TGF-β3 loaded H-MnO2 (TGF-β3/MnO2) effects on nucleus pulposus cells (NPCs) in vitro.
• Evaluation of TGF-β3/MnO2 efficacy in a rat IDD model using MRI and histological analyses.

Main Results:

• H-MnO2 NPs demonstrated a hollow structure and pH/H2O2-responsive drug release.
• TGF-β3/MnO2 significantly suppressed oxidative stress, matrix degradation, and apoptosis in NPCs.
• In vivo studies showed TGF-β3/MnO2 prevented degeneration and promoted regeneration in a rat IDD model.

Conclusions:

• Hollow manganese dioxide nanoplatforms offer a promising strategy for delivering biological factors in IDD.
• Modulating the degenerative microenvironment with nanoplatforms can enhance endogenous repair mechanisms.
• This approach holds potential for effective long-term treatment of intervertebral disc degeneration.